SCHEMBL6984440

SCHEMBL6984440

N=C(N)c1ccc(CCC(=O)N2CCCc3cc(N(CC(=O)O)C(=O)c4ccccc4)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 7/20 0.44
F10 P00742 4/20 0.41
ITGB3 P05106 3/20 0.40
ITGA2B P08514 3/20 0.40
TP53 P04637 1/20 0.38
AVPR2 P30518 1/20 0.38
OXTR P30559 1/20 0.38
AVPR1A P37288 1/20 0.38
NR3C1 P04150 1/20 0.38
PARP1 P09874 1/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
NPC1 O15118 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
PLG P00747 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7084452 0.92 F2 (0.51) F2F10ITGB3ITGA2BTP53
SCHEMBL6985019 0.90 F10 (0.44) F2F10ITGB3ITGA2BTP53
SCHEMBL6982704 0.88 ITGB3 (0.44) ITGB3ITGA2BTP53AVPR2OXTR
Hydrochloric Acid SCHEMBL6981773 0.87 ITGB3 (0.41) F2F10ITGB3ITGA2BTP53
Hydrochloric Acid SCHEMBL6983858 0.86 ALDH1A1 (0.42) F2F10ITGB3ITGA2BTP53
SCHEMBL7948753 0.85 ALDH1A1 (0.44) F2F10ITGB3ITGA2BTP53
Hydrochloric Acid SCHEMBL6974881 0.85 F2 (0.52) F2F10ITGB3ITGA2BNR3C1
Hydrochloric Acid SCHEMBL6984887 0.85 ALDH1A1 (0.43) F2F10ITGB3ITGA2BTP53
SCHEMBL6982322 0.84 NR3C1 (0.47) F2NR3C1ALDH1A1HTT
Hydrochloric Acid SCHEMBL6984865 0.84 F2 (0.41) F2F10ITGB3ITGA2BTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP claimed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US claimed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP claimed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO claimed
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed